MiR-155 inhibition alleviates suppression of osteoblastic differentiation by high glucose and free fatty acids in human bone marrow stromal cells by upregulating SIRT1
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MiR-155 inhibition alleviates suppression of osteoblastic differentiation by high glucose and free fatty acids in human bone marrow stromal cells by upregulating SIRT1
Authors
Keywords
-
Journal
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
Volume 472, Issue 4, Pages 473-480
Publisher
Springer Science and Business Media LLC
Online
2020-04-04
DOI
10.1007/s00424-020-02372-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Relationship between abnormal glucose metabolism and osteoporosis in Han Chinese men over the age of 50 years
- (2019) Minyan Liu et al. Clinical Interventions in Aging
- Gene polymorphism and plasma levels of miR-155 in diabetic retinopathy
- (2019) Evelise Regina Polina et al. Endocrine Connections
- MiR-449 overexpression inhibits osteogenic differentiation of bone marrow mesenchymal stem cells via suppressing Sirt1/Fra-1 pathway in high glucose and free fatty acids microenvironment
- (2018) Bo Qu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- SIRT1 as a Therapeutic Target in Diabetic Complications
- (2018) Justyna Strycharz et al. CURRENT MEDICINAL CHEMISTRY
- MicroRNA-155 inhibits the osteogenic differentiation of mesenchymal stem cells induced by BMP9 via downregulation of BMP signaling pathway
- (2018) Hongxia Liu et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Mesenchymal Stem Cells: Cell Fate Decision to Osteoblast or Adipocyte and Application in Osteoporosis Treatment
- (2018) Lifang Hu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Down-regulation of miR-193a-3p promotes osteoblast differentiation through up-regulation of LGR4/ATF4 signaling
- (2018) Weizhuo Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Upregulation of miR-210 promotes differentiation of mesenchymal stem cells (MSCs) into osteoblasts
- (2018) Ali Asgharzadeh et al. Bosnian Journal of Basic Medical Sciences
- Crocin Inhibits Oxidative Stress and Pro-inflammatory Response of Microglial Cells Associated with Diabetic Retinopathy Through the Activation of PI3K/Akt Signaling Pathway
- (2017) Xinguang Yang et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- miR-155 regulates high glucose-induced cardiac fibrosis via the TGF-β signaling pathway
- (2017) Dong Zhang et al. Molecular BioSystems
- SIRT1 is a positive regulator of the master osteoblast transcription factor, RUNX2
- (2017) Kayvan Zainabadi et al. PLoS One
- miR-155 Inhibits Mouse Osteoblast Differentiation by Suppressing SMAD5 Expression
- (2017) Yue Gu et al. Biomed Research International
- Bone Morphogenetic Protein-9 Enhances Osteogenic Differentiation of Human Periodontal Ligament Stem Cells via the JNK Pathway
- (2017) Pei Wang et al. PLoS One
- High glucose prevents osteogenic differentiation of mesenchymal stem cells via lncRNA AK028326/CXCL13 pathway
- (2016) Boran Cao et al. BIOMEDICINE & PHARMACOTHERAPY
- MicroRNAs in regulation of osteogenic differentiation of mesenchymal stem cells
- (2016) Cong Huang et al. CELL AND TISSUE RESEARCH
- Cellular localization of NRF2 determines the self-renewal and osteogenic differentiation potential of human MSCs via the P53–SIRT1 axis
- (2016) D S Yoon et al. Cell Death & Disease
- Targeted delivery of mesenchymal stem cells to the bone
- (2015) Wei Yao et al. BONE
- Role of SIRT1 and AMPK in mesenchymal stem cells differentiation
- (2013) Huiqiang Chen et al. AGEING RESEARCH REVIEWS
- Runx2: of bone and stretch
- (2007) Panos G. Ziros et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More